Health Condition 1: N852- Hypertrophy of uterus Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA I & ASA II PATIENTS SCHEDULED TOTAL ABDOMINAL HYSTERECTOMY
Exclusion criteria
Exclusion criteria: Patients with baseline Heart rate Patient refusal for study participation . Local infection at injection site. Presence of any coagulopathies or bleeding disorders or patients on anticoagulation. PRESENCE OF NEUROLOGICAL DEFICITS, PERIPHERAL NEUROPATHIES, MYOPATHIES, OR CHRONIC PAIN IN THE OPERATING LIMB. PATIENTS WITH KNOWN ALLERGY TO LOCAL ANAESTHETICS OR TO ANY STUDY DRUGS TO BE USED. HEMODYNAMICALLY COMPROMISED PATIENTS ALCOHOLIC/ PSYCHIATRIC/UNCOOPERATIVE PATIENTS PATIENTS WITH HEPATIC / RENAL OR CARDIOPULMONARY DISORDERS. PATIENTS LESS THAN 5 FEET HEIGHT. TOTAL ABDOMINAL HYSTERECTOMY TAKING > 3 HRS.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dexmedetomidine 10 mcg was a better adjuvant compared to 5 mcg in terms of better post operative analgesia when used as intrathecal adjuvant to Bupivacaine in subarachnoid blockTimepoint: Post operative analgesia assessed every 6 hours after the requirement of first dose of analgesic | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset of sensory block Onset of motor block Level of block achieved Duration of sensory block Duration of motor blockTimepoint: After administration of subarachnoid block Onset of block ever 2 minutes Duration of block every 6 hours | — |
Countries
India
Contacts
Jubilee Mission Medical College and Research Institute